Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Supply Chain
Manufacturing
Novo plant issues may mean delays for Regeneron, Scholar Rock
The FDA has tagged Novo Nordisk's plant in Indiana with an OAI label, which is the most severe of its three inspection classifications.
Kevin Dunleavy
Oct 13, 2025 3:48pm
AZ breaks ground on $4.5B API production facility in Virginia
Oct 9, 2025 1:45pm
Sponsored
BioNTech's African mRNA production push gets EU funding boost
Oct 14, 2025 9:20am
Lilly earmarks $1B-plus for contract manufacturing in India
Oct 6, 2025 11:32am
FDA drafts new policies to boost US drug production
Oct 3, 2025 3:52pm
AbbVie unveils $70M expansion in MA
Oct 1, 2025 9:05am
